Published in Adv Neurol on January 01, 1996
LSVT LOUD and LSVT BIG: Behavioral Treatment Programs for Speech and Body Movement in Parkinson Disease. Parkinsons Dis (2012) 0.91
Effects of home exercise on physical function and activity in home care patients with Parkinson's disease. J Phys Ther Sci (2014) 0.81
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet (1998) 15.09
BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA (1996) 5.95
Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nat Genet (1996) 3.56
Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet (1994) 3.38
Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet (1996) 2.97
Critical illness myopathy and neuropathy. Lancet (1996) 2.71
A descriptive study of BRCA1 testing and reactions to disclosure of test results. Cancer (1997) 2.53
P300-based brain computer interface: reliability and performance in healthy and paralysed participants. Clin Neurophysiol (2006) 2.36
Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer (1996) 2.33
Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes? Am J Hum Genet (1997) 2.15
Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke (1996) 1.84
BRCA1 mutations in Ashkenazi Jewish women. Am J Hum Genet (1995) 1.75
EFNS guideline on mild traumatic brain injury: report of an EFNS task force. Eur J Neurol (2002) 1.73
The role of muscle biopsy in investigating isolated muscle pain. Neurology (2007) 1.54
Serotonin syndrome and rhabdomyolysis induced by concomitant use of triptans, fluoxetine and hypericum. Cephalalgia (2007) 1.46
Needle muscle biopsy in the investigation of neuromuscular disorders. Muscle Nerve (1998) 1.45
A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. Am J Hum Genet (1996) 1.45
Peripheral neurotoxicity of pegylated interferon alpha: a prospective study in patients with HCV. Neurology (2006) 1.42
Initially migraine-like manifestation of a ruptured spinal arteriovenous malformation. Cephalalgia (1995) 1.38
An adult-onset myopathy characterized by a double ring appearance of muscle fibers. Neuromuscul Disord (1991) 1.38
High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCAl-linked families. The Breast Cancer Linkage Consortium. Genes Chromosomes Cancer (1995) 1.34
Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21. Nat Genet (1996) 1.30
C2C12 myoblasts release micro-vesicles containing mtDNA and proteins involved in signal transduction. Exp Cell Res (2010) 1.30
Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives. Pharmacogenetics (2001) 1.23
Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. II. Rhabdomyosarcomas. Am J Pathol (1988) 1.22
The effects of long-term rehabilitation therapy on poststroke hemiplegic patients. Stroke (1993) 1.19
Genetic mapping of the breast-ovarian cancer syndrome to a small interval on chromosome 17q12-21: exclusion of candidate genes EDH17B2 and RARA. Hum Mol Genet (1993) 1.19
Successful treatment of polyarteritis nodosa related to hepatitis B virus with a combination of lamivudine and interferon alpha. Rheumatology (Oxford) (1999) 1.12
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years. J Neurol (2011) 1.11
Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome. Medicine (Baltimore) (1992) 1.11
Biochemistry and histology of the connective tissue of Dupuytren's disease lesions. Eur J Clin Invest (1980) 1.10
Role of the distal balloon protection technique in the prevention of cerebral embolic events during carotid stent placement. Stroke (2001) 1.09
Hereditary and familial ovarian cancer in southern Ontario. Cancer (1994) 1.09
A new mutation in the mitochondrial tRNA(Ala) gene in a patient with ophthalmoplegia and dysphagia. Neuromuscul Disord (2001) 1.09
Generation of a transcription map at the HSD17B locus centromeric to BRCA1 at 17q21. Genomics (1995) 1.07
The genetic basis of Muir-Torre syndrome includes the hMLH1 locus. Am J Hum Genet (1996) 1.07
Effects of isoflurane anesthesia on local cerebral glucose utilization in the rat. Anesthesiology (1986) 1.01
Localization of oxytocin binding sites in the human brainstem and upper spinal cord: an autoradiographic study. Brain Res (1989) 1.00
Clinical predictors in Parkinson's disease. Neurol Sci (2002) 1.00
Osteoporosis and body composition. J Endocrinol Invest (2007) 1.00
Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families. Br J Cancer (2012) 1.00
Effects of GM1 ganglioside in cerebrovascular diseases: a double-blind trial in 40 cases. Eur Neurol (1985) 0.98
Cortical regions contributing to the anterior commissure in man. Exp Brain Res (1999) 0.98
Mild traumatic brain injury. Eur J Neurol (2012) 0.98
Identification of three novel mutations in non-Ashkenazi Italian patients with muscle phosphofructokinase deficiency. Am J Hum Genet (1994) 0.97
Health-related quality of life and sleep disorders in Parkinson's disease. Neurol Sci (2003) 0.97
Mutation analysis of the BRCA1 gene in 23 families with cases of cancer of the breast, ovary, and multiple other sites. J Med Genet (1996) 0.96
BRCA2 hereditary breast cancer pathophenotype. Breast Cancer Res Treat (1997) 0.95
The effects of propofol anesthesia on local cerebral glucose utilization in the rat. Anesthesiology (1990) 0.94
Neurolupus is associated with anti-ribosomal P protein antibodies: an inception cohort study. J Autoimmun (2009) 0.94
Virtual Reality as an assessment tool for arm motor deficits after brain lesions. Stud Health Technol Inform (2001) 0.93
On the prognosis of outcome after stroke. Acta Neurol Scand (1999) 0.92
Histology of BRCA1-associated ovarian tumours. Lancet (1994) 0.89
Increased expression of the normal cellular isoform of prion protein in inclusion-body myositis, inflammatory myopathies and denervation atrophy. Brain Pathol (2001) 0.88
NMR method for superoxide dismutase assay in brain and liver homogenates. J Biochem Biophys Methods (1991) 0.87
BRCA1 mutations and survival in women with ovarian cancer. N Engl J Med (1997) 0.87
Confirmation of FWT1 as a Wilms' tumour susceptibility gene and phenotypic characteristics of Wilms' tumour attributable to FWT1. Hum Genet (1998) 0.87
Hereditary nonpolyposis colon cancer: analysis of linkage to 2p15-16 places the COCA1 locus telomeric to D2S123 and reveals genetic heterogeneity in seven Canadian families. Am J Hum Genet (1994) 0.87
Diabetes as a risk factor for cognitive decline in older patients. Dement Geriatr Cogn Disord (2008) 0.87
The uptake of various amino acids by the mouse brain in vivo. Brain Res (1971) 0.87
Free light chains in the CSF in multiple sclerosis. J Neurol (1987) 0.87
Dementia of the frontal type: neuropsychological and [99Tc]-HM-PAO SPET features. J Geriatr Psychiatry Neurol (1995) 0.86
Pediatric medulloblastoma: prognostic value of p53, bcl-2, Mib-1, and microvessel density. J Neurooncol (1999) 0.85
Activation of NF-kappaB p65/c-Rel dimer is associated with neuroprotection elicited by mGlu5 receptor agonists against MPP(+) toxicity in SK-N-SH cells. J Neural Transm (Vienna) (2007) 0.85
Clinical, morphological and genetic studies in a cohort of 21 patients with myofibrillar myopathy. Acta Myol (2011) 0.84
The familial Wilms' tumour susceptibility gene, FWT1, may not be a tumour suppressor gene. Oncogene (1997) 0.84
Effects of acute and chronic treatment with fluoxetine on regional glucose cerebral metabolism in rats: implications for clinical therapies. Brain Res (2000) 0.83
Prevalence of founder BRCA1 and BRCA2 mutations in unselected French Canadian women with breast cancer. Clin Genet (2001) 0.83
Well differentiated cerebellar tissue within a mature cystic teratoma. Pathol Res Pract (1998) 0.83
A short review of cognitive and functional neuroimaging studies of cholinergic drugs: implications for therapeutic potentials. J Neural Transm (Vienna) (2002) 0.83
Expression of protein kinase C isoforms and interleukin-1beta in myofibrillar myopathy. Neurology (2004) 0.82
Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosis. J Neurol Neurosurg Psychiatry (2006) 0.82
Single photon emission computed tomography with [99Tc]-HM-PAO and [123I]-IBZM in Alzheimer's disease and dementia of frontal type: preliminary results. Acta Neurol Scand (1994) 0.82
Immunity status to poliovirus in Veneto region (north-east Italy). A seroepidemiological survey. Ann Clin Lab Sci (1995) 0.82
Reduced striatal dopamine receptors in Alzheimer's disease: single photon emission tomography study with the D2 tracer [123I]-IBZM. Neurology (1996) 0.82
A splice junction mutation in a new myopathic variant of phosphoglycerate kinase deficiency (PGK North Carolina). Ann Neurol (1994) 0.81
Haloperidol and cerebral metabolism in the conscious rat: relation to pharmacokinetics. J Neurochem (1984) 0.81
Transcription factors c-Jun/activator protein-1 and nuclear factor-kappa B in oxidative stress response in mitochondrial diseases. Neuropathol Appl Neurobiol (2003) 0.81
Sarcoidosis and inclusion body myositis. Rheumatology (Oxford) (2008) 0.81
A high proportion of mutations in the BRCA1 gene in German breast/ovarian cancer families with clustering of mutations in the 3' third of the gene. Hum Genet (1998) 0.81
Muscle cytochrome c oxidase deficiency in two Italian patients with ethylmalonic aciduria and peculiar clinical phenotype. J Inherit Metab Dis (1994) 0.81
Regional cerebral blood flow study with 99mTc-hexamethyl-propyleneamine oxime single photon emission computed tomography in Alzheimer's and multi-infarct dementia. Eur Neurol (1990) 0.81
Corticobasal degeneration: neuropsychological assessment and dopamine D2 receptor SPECT analysis. Eur Neurol (1995) 0.81